Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species.

Gavin PJ, Suseno MT, Thomson RB Jr, Gaydos JM, Pierson CL, Halstead DC, Aslanzadeh J, Brecher S, Rotstein C, Brossette SE, Peterson LR.

Antimicrob Agents Chemother. 2006 Jun;50(6):2244-7.

2.

The effectiveness of standard povidone iodine surgical preparation in decontaminating external fixator components.

Hak DJ, Wiater PJ, Williams RM, Pierson CL.

Injury. 2005 Dec;36(12):1449-52. Epub 2005 Oct 21.

PMID:
16243337
3.

Genomic analysis of penicillin-resistant Streptococcus pneumoniae in Southeastern Michigan.

Yee EK, Melkerson-Watson LJ, Bloch CA, Pierson CL, Blackwood RA.

J Infect. 2004 Aug;49(2):126-35.

PMID:
15236919
4.

Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis.

Reed BD, Zazove P, Pierson CL, Gorenflo DW, Horrocks J.

J Womens Health (Larchmt). 2003 Dec;12(10):979-89.

5.

Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women.

Manning SD, Foxman B, Pierson CL, Tallman P, Baker CJ, Pearlman MD.

Obstet Gynecol. 2003 Jan;101(1):74-9.

PMID:
12517649
6.

Increased C5a receptor expression in sepsis.

Riedemann NC, Guo RF, Neff TA, Laudes IJ, Keller KA, Sarma VJ, Markiewski MM, Mastellos D, Strey CW, Pierson CL, Lambris JD, Zetoune FS, Ward PA.

J Clin Invest. 2002 Jul;110(1):101-8.

7.

Frequency of antibiotic resistance among group B Streptococcus isolated from healthy college students.

Manning SD, Pearlman MD, Tallman P, Pierson CL, Foxman B.

Clin Infect Dis. 2001 Dec 15;33(12):E137-9. Epub 2001 Nov 5.

PMID:
11698992
8.
9.

Sexual behaviors and other risk factors for Candida vulvovaginitis.

Reed BD, Gorenflo DW, Gillespie BW, Pierson CL, Zazove P.

J Womens Health Gend Based Med. 2000 Jul-Aug;9(6):645-55.

10.

APNs in home care.

Pierson CL.

Am J Nurs. 1999 Oct;99(10):22-3. No abstract available.

PMID:
10542842
11.

Protective effects of C5a blockade in sepsis.

Czermak BJ, Sarma V, Pierson CL, Warner RL, Huber-Lang M, Bless NM, Schmal H, Friedl HP, Ward PA.

Nat Med. 1999 Jul;5(7):788-92.

PMID:
10395324
12.

Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin.

Pearlman MD, Pierson CL, Faix RG.

Obstet Gynecol. 1998 Aug;92(2):258-61.

PMID:
9699763
13.

Ureaplasma urealyticum and chronic lung disease in very low birth weight infants during the exogenous surfactant era.

Perzigian RW, Adams JT, Weiner GM, Dipietro MA, Blythe LK, Pierson CL, Faix RG.

Pediatr Infect Dis J. 1998 Jul;17(7):620-5.

PMID:
9686729
14.

Pulsed-field gel electrophoresis genomic fingerprinting of hospital Escherichia coli bacteraemia isolates.

Blackwood RA, Rode CK, Pierson CL, Bloch CA.

J Med Microbiol. 1997 Jun;46(6):506-10.

PMID:
9350204
15.

Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.

Snydman DR, McDermott L, Cuchural GJ Jr, Hecht DW, Iannini PB, Harrell LJ, Jenkins SG, O'Keefe JP, Pierson CL, Rihs JD, Yu VL, Finegold SM, Gorbach SL.

Clin Infect Dis. 1996 Dec;23 Suppl 1:S54-65.

PMID:
8953108
17.

Evaluation of the new DrySlide beta-lactamase test.

Dyke JW, Brown WJ, Morris JM, Pierson CL, Peters EM.

Am J Clin Pathol. 1994 Jun;101(6):726-8.

PMID:
8209859
18.

Comparison of Difco ESP and Organon Teknika BacT/Alert continuous-monitoring blood culture systems.

Zwadyk P Jr, Pierson CL, Young C.

J Clin Microbiol. 1994 May;32(5):1273-9.

19.

A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States.

Aldridge KE, Gelfand M, Reller LB, Ayers LW, Pierson CL, Schoenknecht F, Tilton RC, Wilkins J, Henderberg A, Schiro DD, et al.

Diagn Microbiol Infect Dis. 1994 Apr;18(4):235-41.

20.

Detection and characterization of atypical mycobacteria by the polymerase chain reaction.

Cook SM, Bartos RE, Pierson CL, Frank TS.

Diagn Mol Pathol. 1994 Mar;3(1):53-8.

PMID:
8162256
21.

Genetic similarity of Candida albicans strains from vaginitis patients and their partners.

Schmid J, Rotman M, Reed B, Pierson CL, Soll DR.

J Clin Microbiol. 1993 Jan;31(1):39-46.

22.

Molecular typing of ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium isolates from diverse geographic areas.

Donabedian SM, Chow JW, Boyce JM, McCabe RE, Markowitz SM, Coudron PE, Kuritza A, Pierson CL, Zervos MJ.

J Clin Microbiol. 1992 Nov;30(11):2757-61.

23.

Evaluation of a latex agglutination test for the identification of Candida species in vaginal discharge.

Reed BD, Pierson CL.

J Am Board Fam Pract. 1992 Jul-Aug;5(4):375-80.

PMID:
1496893
24.

Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.

Pierson CL, Friedman BA.

Diagn Microbiol Infect Dis. 1992 Feb;15(2 Suppl):19S-30S.

PMID:
1737439
25.

Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.

Cuchural GJ Jr, Snydman DR, McDermott L, Iannini PB, Hill GB, Cleary TJ, O'Keefe JP, Pierson CL, Rihs JD, Finegold SM.

Clin Ther. 1992 Jan-Feb;14(1):122-36.

PMID:
1576621
26.

Effect of controlled hemorrhage on tissue and serum cefazolin clearance.

Brothers TE, Wakefield TW, Schaberg DR, Pierson CL, Graham LM, Stanley JC.

J Surg Res. 1991 Sep;51(3):223-8.

27.

Artery, periarterial adipose tissue, and blood microbiology during vascular reconstructive surgery: perioperative and early postoperative observations.

Wakefield TW, Pierson CL, Schaberg DR, Messina LM, Lindenauer SM, Greenfield LJ, Zelenock GB, Stanley JC.

J Vasc Surg. 1990 May;11(5):624-8.

PMID:
2335832
28.
29.

Bacteriology of pustules occurring during treatment of psoriasis.

Gupta AK, Pierson CL, Rasmussen JE, Weiss JS.

Arch Dermatol. 1987 Jul;123(7):890-2.

PMID:
3606166
30.

Treatment of established prosthetic vascular graft infection with antibiotics preferentially concentrated in leukocytes.

Wakefield TW, Schaberg DR, Pierson CL, Bouffard JA, Petry NA, Nolan KD, Spaulding SA, Whitehouse WM Jr, Stanley JC.

Surgery. 1987 Jul;102(1):8-14.

PMID:
3589979
31.

Protothecal olecranon bursitis: treatment with intrabursal amphotericin B.

Cochran RK, Pierson CL, Sell TL, Palella T.

Rev Infect Dis. 1986 Nov-Dec;8(6):952-4.

PMID:
3797938
32.

The Tzanck smear in the diagnosis of cutaneous herpes simplex.

Solomon AR, Rasmussen JE, Varani J, Pierson CL.

JAMA. 1984 Feb 3;251(5):633-5.

PMID:
6317901
33.

Permeation of skin and eschar by antiseptics II: influence of controlled burns on the permeation of phenol.

Behl CR, Linn EE, Flynn GL, Ho NF, Higuchi WI, Pierson CL.

J Pharm Sci. 1983 Apr;72(4):397-400.

PMID:
6864478
34.

Permeation of skin and eschar by antiseptics I: baseline studies with phenol.

Behl CR, Linn EE, Flynn GL, Pierson CL, Higuchi WI, Ho NF.

J Pharm Sci. 1983 Apr;72(4):391-7.

PMID:
6864477
35.

Susceptibility of the Bacteroides fragilis group in the United States in 1981.

Tally FP, Cuchural GJ, Jacobus NV, Gorbach SL, Aldridge KE, Cleary TJ, Finegold SM, Hill GB, Iannini PB, McCloskey RV, O'Keefe JP, Pierson CL.

Antimicrob Agents Chemother. 1983 Apr;23(4):536-40.

36.

Hydration and percutaneous absorption III: Influences of stripping and scalding on hydration alteration of the permeability of hairless mouse skin to water and n-alkanols.

Behl CR, Barrett M, Flynn GL, Kurihara T, Walters A, Gatmaitkan OG, Harper N, Higuchi WI, Ho NF, Pierson CL.

J Pharm Sci. 1982 Feb;71(2):229-34.

PMID:
7062251
37.

In-vitro activity of Sch 29482, MK 0787, ceftriaxone and seven other antimicrobials against 840 separate clinical isolates.

Pierson CL, Schaberg DR, Fekety FR Jr, McClatchey KD.

J Antimicrob Chemother. 1982 Feb;9 Suppl C:79-89. No abstract available.

PMID:
6277844
38.

Permeability of thermally damaged skin v: permeability over the course of maturation of a deep partial-thickness wound.

Flynn GL, Behl CR, Linn E, Higuchi WI, Ho NF, Pierson CL.

Burns Incl Therm Inj. 1982 Jan;8(3):196-202.

PMID:
7059862
39.

Technique for preparing appendage-free skin (scar) on hairless mouse.

Behl CR, Wittkowsky A, Barrett M, Pierson CL, Flynn GL.

J Pharm Sci. 1981 Jul;70(7):835-7. No abstract available.

PMID:
7264946
40.

Infection control in burn care facilities.

Pierson CL.

CCQ. 1981 Mar;3(4):81-92. No abstract available.

PMID:
10249952
41.

Hydration and percutaneous absorption: I. Influence of hydration on alkanol permeation through hairless mouse skin.

Behl CR, Flynn GL, Kurihara T, Harper N, Smith W, Higuchi WI, Ho NF, Pierson CL.

J Invest Dermatol. 1980 Oct;75(4):346-52.

42.

Permeability of thermally damaged skin: I. Immediate influences of 60 degrees C scalding on hairless mouse skin.

Behl CR, Flynn GL, Kurihara T, Smith W, Gatmaitan O, Higuchi WI, Ho NF, Pierson CL.

J Invest Dermatol. 1980 Oct;75(4):340-5.

43.

Effect of cyclophosphamide on the immune response to Pseudomonas aeruginosa in mice.

Pierson CL, Johnson AG, Feller I.

Infect Immun. 1976 Jul;14(1):168-77.

44.

The use of immunotherapy for the prevention of opportunistic gram-negative infections.

Pierson CL.

Surg Clin North Am. 1972 Dec;52(6):1473-81. No abstract available.

PMID:
4635662
45.

Diagnosis and treatment of postoperative bacterial sepsis.

Feller I, Fekety F, Richards KE, Pierson CL, Murphy J.

Surg Clin North Am. 1972 Dec;52(6):1391-8. No abstract available.

PMID:
4635657
46.

Prevention of postoperative infections.

Feller I, Richards KE, Pierson CL.

Surg Clin North Am. 1972 Dec;52(6):1361-6. No abstract available.

PMID:
4635654
47.

Monilial sepsis in the surgical patient.

Richards KE, Pierson CL, Bucciarelli L, Feller I.

Surg Clin North Am. 1972 Dec;52(6):1399-406. No abstract available.

PMID:
4344114

Supplemental Content

Loading ...
Support Center